In recent years, with the rapid advancement of medical science, specialization in clinical disciplines has become an inevitable trend. In this context, our hospital has established the Digestive Diseases Diagnosis and Treatment Center, which includes the Department of Hepatobiliary and Pancreatic Medicine and the Department of Gastroenterology.
The Department of Hepatobiliary and Pancreatic Medicine is part of a hospital affiliated with a Ministry of Education-supported "211 Project" university. It is a clinical department that integrates medical services, education, and research, and is authorized to confer doctoral degrees. The department director is Professor Jin Zhenjing, who serves as a member of the Liver Disease Prevention and Treatment Group of the Chinese Medical Association, a member of the Jilin Provincial Medical Doctor Association's Gastroenterology Branch, and a member of the Jilin Provincial Medical Association's Digestive Endoscopy Branch.
The department has a well-structured team of medical professionals.
In clinical practice, a comprehensive three-tiered ward round and consultation system has been established. For complex and critically ill patients, expert consultations involving the entire department are organized, with physicians at all levels participating in discussions. For interdisciplinary cases, hospital-wide consultations are arranged. Emphasis is placed on collaboration across departments, working closely with the Interventional Radiology Department and the Diagnostic Ultrasound Department to develop new technologies and treatments. These include partial splenic artery embolization for complications of liver cirrhosis, ultrasound-guided liver cyst puncture and drainage, percutaneous transhepatic cholangiography (PTC) and drainage, ultrasound-guided liver biopsy, and interventional therapy for liver cancer.
The department has achieved nationally leading levels in the diagnosis and treatment of various critical and complex conditions, including hepatitis, fatty liver disease, liver cirrhosis and its complications, liver cancer, biliary diseases, and pancreatitis:
Diagnosis and treatment of chronic viral hepatitis: Leveraging the department's independent laboratory, tests such as quantitative detection of hepatitis B and C viruses, viral genotyping, and genetic drug resistance monitoring can be performed. This enables systematic and standardized diagnosis and treatment of chronic hepatitis B and C.
Diagnosis and treatment of liver fibrosis, cirrhosis, and fatty liver disease: The department has introduced transient elastography (FibroScan) to achieve non-invasive, painless, rapid, and accurate quantitative diagnosis of fatty liver. Combined with the four serum biomarkers of liver fibrosis, it allows for precise diagnosis of liver fibrosis and assessment of liver stiffness.
Early diagnosis of digestive tract tumors: Utilizing multiple digestive system tumor marker tests conducted in the department's laboratory, along with relevant imaging examinations, enables early screening and timely diagnosis of tumors.
Meanwhile, the department actively promotes multidisciplinary and multi-center collaboration to achieve standardized diagnosis and treatment for various diseases:
In collaboration with the Radiology Department, Pathology Department, Ultrasound Department, Hepatobiliary and Pancreatic Surgery Department, and Interventional Therapy Department, a multidisciplinary team (MDT) process for the diagnosis and treatment of liver nodules has been established, reflecting the distinctive approach of our hospital.
Working with the Gastroenterology Department, Ultrasound Department, Pathology Department, Hepatobiliary and Pancreatic Surgery Department, and Interventional Therapy Department, an MDT process for the diagnosis and treatment of obstructive jaundice has been developed.
Collaboration with the Hepatobiliary and Pancreatic Surgery Department enhances perioperative medical management for patients with liver-related diseases, providing comprehensive support for surgical operations. The two departments also work closely together to systematically and standardly diagnose and treat severe pancreatitis, reducing mortality rates among such patients.
The Department of Hepatobiliary and Pancreatic Medicine plans to establish public science education days, such as:
Organizing events like "Love Your Liver Day" and "Liver-Gallbladder Partnership Day";
Cooperating with primary-level hospitals: holding regular academic exchanges;
Establishing a "Patient Club" to conduct various popular science lectures;
Providing free medical consultations: offering free clinics in hospitals and communities to facilitate access to medical care for the general public.
